$4.370
+0.020 (+0.46%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
STLA Prediction & Forecast by Similar Chart Analysis
Alphio's STLA stock price prediction model matches the current Stellantis NV tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $4.38 (+0.30%). The 1-week path is $4.38 (+0.30%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Stellantis NV Stock?
Stellantis NV is not a good buy right now. The current price is $4.37, which is significantly below the analyst price targets of $5.20 and $4, indicating limited upside potential. Additionally, the forward P/E ratio is 5.19, suggesting that the stock is undervalued, but the negative 61.73% year-to-date change raises concerns about its performance. The main risk is the company's negative earnings expectations, with an EPS estimate of -0.07 for the next earnings report, reflecting ongoing financial challenges.
STLA stock price ended at $4.37 on Friday, after rising +0.46%
Stellantis NV (STLA) last closed at $4.37, gaining +0.46%. These facts feed the 1-day and 1-week STLA price prediction above.
Forecast Drivers
Stellantis NV (STLA) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches STLA, ranked by similarity.
Seasonality analysis for STLA
Historically the probability of a positive October return for STLA is 0.00%. February offers the highest probability of a positive month at 56.90%, while June is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.